Lipella Pharmaceuticals, PRISM MarketView, Biotech, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ, LIPO, Public Health Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished Thomas Wolff Dec 20, 2023 9:11:40 AM -Lipella Granted Two Orphan Drug Designations by FDA- Read more
PRISM MarketView, Stock Market, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100% Thomas Wolff Dec 13, 2023 3:28:23 PM Read more
PRISM MarketView, Stock Market, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan Thomas Wolff Dec 13, 2023 3:04:47 PM Read more
PRISM MarketView, Biotech, Stock Market, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ PRISM MarketView Biotech Index Top Mover Spotlight: Kamada (KMDA) Thomas Wolff Dec 7, 2023 1:14:41 PM Read more
PRISM MarketView, Stock Market, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ, Oncology, OCX Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays Thomas Wolff Dec 6, 2023 10:33:17 AM Read more
PRISM MarketView, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ PRISM MARKETVIEW HIGHLIGHTS ALTIMMUNE’S POSITIVE TOPLINE RESULTS IN OBESITY DRUG TRIAL Thomas Wolff Dec 5, 2023 4:30:59 PM Read more
Lipella Pharmaceuticals, PRISM MarketView, Biotech, Stock Market, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ, Oncology, LIPO Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug Thomas Wolff Nov 10, 2023 11:21:36 AM Read more
PRISM MarketView, Stock Market, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, NASDAQ, Oncology, OCX Oncocyte Reports Third Quarter 2023 Financial Results Thomas Wolff Nov 9, 2023 1:49:41 PM Read more
PRISM MarketView, OTC Markets, Biotech, Stock Market, Healthcare, PRISM DigitalMedia, Pharmaceutical, PRISM MediaWire, Stock Index, NASDAQ PRISM MarketView Insight: Is It Time to Invest in Small-Cap Stocks? Thomas Wolff Nov 7, 2023 11:33:22 AM Read more